Shijiazhuang, China's new hotspot of COVID-19 surge

▴ Shijiazhuang, China's new hotspot of COVID-19 surge
Shijiazhuang, the provincial capital of North China's Hebei Province has become China's new hotspot of Coronavirus surge. Of the 82 confirmed COVID-19 cases yesterday, all of which were locally-transmitted, 77 were reported in Shijiazhuang and the other five in the city of Xingtai.

Shijiazhuang, the provincial capital of North China's Hebei Province has become China's new hotspot of Coronavirus surge. Of the 82 confirmed COVID-19 cases yesterday, all of which were locally-transmitted, 77 were reported in Shijiazhuang and the other five in the city of Xingtai.

Hebei reported 131 COVID positive cases including 49 asymptomatic cases as announced by the provincial health commission. Shijiazhuang has begun the second round of citywide nucleic acid testing.

In last week, the city reported 369 confirmed COVID-19 cases and asymptomatic cases, all of whom are treated at designated hospitals. Meanwhile, as per state media reports, medical teams from Tianjin and Hunan are reaching Hebei Province to support COVID-19 control and prevention.

The Zhongnan Hospital of Wuhan University sent a vehicle-carried mobile CT scanner to Hebei. By the end of Sunday, there were 267 confirmed cases admitted in hospitals in Hebei. A total of 208 asymptomatic cases are under medical observation.

The Chinese mainland yesterday reported 179 COVID positive cases including 76 asymptomatic cases, the National Health Commission said today. Of the 85 locally transmitted confirmed cases, 82 were reported in north China's Hebei Province, two in Liaoning Province, and one in Beijing.

Beijing also reported four asymptomatic cases. The total number of confirmed COVID-19 cases on the mainland reached 87,536 yesterday, including 673 patients still receiving treatment, 20 of whom were in severe condition.

Tags : #ChinasLatestCovidUpdates #Shijiazhuang #Hotspot #CoronaVirusSurge #NewCovid-19Cases #provincialhealthcommission #TotalActiveCovidCases #DailyCovidUpdates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024